2014 Journal Article Resveratrol does not benefit patients with non-alcoholic fatty liver diseaseChachay, Veronique S., Macdonald, Graeme A., Martin, Jennifer H., Whitehead, Jonathan P., O’Moore-Sullivan, Trisha M., Lee, Paul, Franklin, Michael, Klein, Kerenaftali, Taylor, Paul J., Ferguson, Maree, Coombes, Jeff S., Thomas, Gethin P., Cowin, Gary J., Kirkpatrick, Carl M. J., Prins, Johannes B. and Hickman, Ingrid J. (2014). Resveratrol does not benefit patients with non-alcoholic fatty liver disease. Clinical Gastroenterology and Hepatology, 12 (12), 2092-2103.e6. doi: 10.1016/j.cgh.2014.02.024 |
2014 Conference Publication Pre-operative cardiorespiratory fitness and post-operative cardiometabolic disease in liver transplant recipientsWallen, M. P., Woodward, A., Skinner, T. L., Macdonald, G. A. and Coombes, J. S. (2014). Pre-operative cardiorespiratory fitness and post-operative cardiometabolic disease in liver transplant recipients. Australian Gastroenterology Week 2014, Broadbeach, QLD Australia, 22-24 October 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.12736_5 |
2014 Conference Publication Hepatic fibrosis is associated with small intestinal permeability in chronic liver disease due to hepatitis C, hepatitis B and non-alcoholic fatty liver disease, in subjects without ascites. A prospective cohort study using non-invasive techniquesRaj, Ashok, Holtmann, Gerald, Bhat, Purnima, Fletcher, Linda, Tran, Cuong, Vesey, David and Macdonald, Graeme (2014). Hepatic fibrosis is associated with small intestinal permeability in chronic liver disease due to hepatitis C, hepatitis B and non-alcoholic fatty liver disease, in subjects without ascites. A prospective cohort study using non-invasive techniques. Asian Pacific Digestive Week, Bali, Indonesia, 22‐25, 2014. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia . doi: 10.1111/jgh.12766_2 |
2014 Journal Article Total body fat and the risk of Barrett's oesophagus - A bioelectrical impedance studyKendall, Bradley J., Macdonald, Graeme A., Prins, Johannes B., O'Brien, Suzanne and Whiteman, David C. (2014). Total body fat and the risk of Barrett's oesophagus - A bioelectrical impedance study. Cancer Epidemiology, 38 (3), 266-272. doi: 10.1016/j.canep.2014.03.006 |
2014 Conference Publication Fat oxidation over a range of exercise intensities: fitness versus fatnessCroci, Ilaria, Hickman, Ingrid J., Wood, Rachel E., Borrani, Fabio, Macdonald, Graeme A. and Byrne, Nuala M. (2014). Fat oxidation over a range of exercise intensities: fitness versus fatness. 6th Exercise and Sport Science Australia Conference, Adelaide, SA, Australia, 10-12 April 2014. |
2013 Journal Article Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver diseaseCroci, Ilaria, Byrne, Nuala M., Choquette, Stephane, Hills, Andrew P., Chachay, Veronique S., Clouston, Andrew D., O'Moore-Sullivan, Trisha M., Macdonald, Graeme A., Prins, Johannes B. and Hickman, Ingrid J. (2013). Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease. Gut, 62 (11), 1625-1633. doi: 10.1136/gutjnl-2012-302789 |
2013 Journal Article A Pilot Randomised Study of the Metabolic and Histological Effects of Exercise in Non-alcoholic SteatohepatitisHickman, Ingrid J., Byrne, Nuala M., Croci, Ilaria, Chachay, Veronique S., Clouston, Andrew D., Hills, Andrew P., Bugianesi, Elisabetta, Whitehead, Jonathan P, Gastaldelli, Amalia, O'Moore-Sullivan, Trisha M., Prins, Johannes B. and Macdonald, Graeme A . (2013). A Pilot Randomised Study of the Metabolic and Histological Effects of Exercise in Non-alcoholic Steatohepatitis. Journal of Diabetes and Metabolism, 4 (8) 8. doi: 10.4172/2155-6156.1000300 |
2013 Journal Article The risk of Barrett's esophagus associated with abdominal obesity in males and femalesKendall, Bradley J., Macdonald, Graeme A., Hayward, Nicholas K., Prins, Johannes B., O'Brien, Suzanne, Whiteman, David C., Study of Digestive Health, Green. Adele C., Parsons, Peter G., Pavey, Sandra J., Purdie, David M. and Webb, Penelope M. (2013). The risk of Barrett's esophagus associated with abdominal obesity in males and females. International Journal of Cancer, 132 (9), 2192-2199. doi: 10.1002/ijc.27887 |
2013 Conference Publication Obstructive Sleep Apnea, Gastroesophageal Reflux and Barrett's Esophagus in a Population-Based Case-Control StudyLindam, Anna P., Kendall, Bradley J., Thrift, Aaron P., Macdonald, Graeme A., Lagergren, Jesper and Whiteman, David C. (2013). Obstructive Sleep Apnea, Gastroesophageal Reflux and Barrett's Esophagus in a Population-Based Case-Control Study. Digestive Disease Week / 28th Annual Residents and Fellows Research Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT), Orlando Fl, May 18-21, 2013. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC. |
2013 Conference Publication Advanced Hepatic Fibrosis Is Associated With Increased Small Intestinal Permeability: A Novel Evaluation Incorporating a Plasma-Based Assay and Transient ElastographyRaj, Ashok, Macdonald, Graeme A., Bhat, Purnima, Tran, Cuong D. and Holtmann, Gerald (2013). Advanced Hepatic Fibrosis Is Associated With Increased Small Intestinal Permeability: A Novel Evaluation Incorporating a Plasma-Based Assay and Transient Elastography. Digestive Disease Week / 28th Annual Residents and Fellows Research Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT), Orlando Florida, 18 - 21 May, 2013. Philadelphia, United States of America: Elsevier Inc.. |
2013 Journal Article Use of standardised assessment forms in referrals to hepatology outpatient services: implications for accurate triaging of patients with chronic hepatitis CHorsfall, Leigh, Macdonald, Graeme, Scott, Ian, Skoien, Richard, Khatun, Mohsina, Moss, Cathy, Seligman, Clare, Kardash, Christine, Poxon, Vicki and Powell, Elizabeth E. (2013). Use of standardised assessment forms in referrals to hepatology outpatient services: implications for accurate triaging of patients with chronic hepatitis C. Australian Health Review, 37 (2), 218-222. doi: 10.1071/AH12162 |
2013 Conference Publication Management and outcomes of side effects with focus on anaemia in patients with hepatitis c genotype 1 infection: The telaprevir early access program in patients from Australia and New ZealandStrasser, S. I., Roberts, S. K., Gane, E. J., Macdonald, G. A., Thompson, A. J., Weltman, M. D., Weilert, F., Hill, A., Laeuffer, J. and Dore, G. J. (2013). Management and outcomes of side effects with focus on anaemia in patients with hepatitis c genotype 1 infection: The telaprevir early access program in patients from Australia and New Zealand. The Australian Gastroenterology Week 2013, Melbourne, VIC Australia, 7 - 9 October 2013. Richmond, VIC 3121 Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.12365_14 |
2013 Book Chapter Physical activity and cardiovascular fitness in patients with NAFLD: Clinical importance and therapeutic implicationsHickman, Ingrid J., Macdonald, Graeme A. and Byrne, Nuala M. (2013). Physical activity and cardiovascular fitness in patients with NAFLD: Clinical importance and therapeutic implications. Non-alcoholic fatty liver disease : A practical guide. (pp. 132-148) Chichester, W Sussex, U,K.: Wiley-Blackwell. doi: 10.1002/9781118556153.ch12 |
2013 Conference Publication Significant hepatic fibrosis is associated with increased small intestinal permeabilityRaj, A. S., Macdonald, G. A., Bhat, P., Fletcher, L. M., Tran, C., Black, M. and Holtmann, G. (2013). Significant hepatic fibrosis is associated with increased small intestinal permeability. The Australian Gastroenterology Week 2013, Melbourne, VIC Australia, 7 - 9 October 2013. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.12365_5 |
2013 Conference Publication Investigating the clinical effect of resveratrol in non-alcoholic fatty liver disease: a randomised, double blind, placebo-controlled trialChachay, V. S., Martin, J. H., Prins, J. B., Whitehead, J. P., O'Moore-Sullivan, T. M., Lee, P., Franklin, M., Klein, K., Taylor, P. J., Ferguson, M., Coombes, J. S., Thomas, G. P., Cowin, G. J., Kirkpatrick, C. M. J., Macdonald, G. A. and Hickman, I. J. (2013). Investigating the clinical effect of resveratrol in non-alcoholic fatty liver disease: a randomised, double blind, placebo-controlled trial. Australian Gastroenterology Week 2013, Melbourne, VIC, Australia, 7-9 October 2013. Richmond, VIC, Australia: Wiley-Blackwell. doi: 10.1111/jgh.12365_5 |
2013 Conference Publication Trends in treatment of recurrent hepatitis C after liver transplantationForgan-Smith, K. R., Stuart, K. A., Tallis, C., Macdonald, G. A. and Fawcett, J. (2013). Trends in treatment of recurrent hepatitis C after liver transplantation. The Australian Gastroenterology Week 2013, Melbourne, VIC Australia, 7 - 9 October 2013. Richmond, VIC 3121 Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.12365_14 |
2013 Conference Publication Abdominal obesity and Barrett's oesophagus - does hip obesity reduce the risk?Kendall, B. J., Macdonald, G. A., Prins, J. B., O'Brien, S. and Whiteman, D. C. (2013). Abdominal obesity and Barrett's oesophagus - does hip obesity reduce the risk?. Australian Gastroenterology Week 2013, Melbourne Australia, 7-9 October 2013. Richmond Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.12365_7 |
2013 Conference Publication Treatment of hepatitis c genotype 1 patients with severe fibrosis or compensated cirrhosis: The telaprevir early access program in patients from Australia and New ZealandMacdonald, G. A., Roberts, S. K., Dore, G. J., Gane, E. J., Thompson, A. J., Weltman, M. D., Weilert, F., Hill, A., Laeuffer, J. and Strasser, S. I. (2013). Treatment of hepatitis c genotype 1 patients with severe fibrosis or compensated cirrhosis: The telaprevir early access program in patients from Australia and New Zealand. The Australian Gastroenterology Week 2013, Melbourne, VIC Australia, 7 - 9 October 2013. Richmond, VIC 3121 Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.12365_14 |
2012 Journal Article The serum hepcidin:ferritin ratio is a potential biomarker for cirrhosisTan, Terrence C. H., Crawford, Darrell H. G., Franklin, Michael E., Jaskowski, Lesley A., Macdonald, Graeme A., Jonsson, Julie R., Watson, Melanie J., Taylor, Paul J. and Fletcher, Linda M. (2012). The serum hepcidin:ferritin ratio is a potential biomarker for cirrhosis. Liver International, 32 (9), 1391-1399. doi: 10.1111/j.1478-3231.2012.02828.x |
2012 Journal Article Hepatitis C treatment outcomes in Australian clinicsGidding, Heather F., Law, Matthew G., Amin, Janaki, Ostapowicz, George, Weltman, Martin, Macdonald, Graeme A., Sasadeusz, Joe J., Haber, Paul A. W., George, Jacob and Dore, Gregory J. (2012). Hepatitis C treatment outcomes in Australian clinics. Medical Journal of Australia, 196 (10), 633-637. doi: 10.5694/mja12.10014 |